直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Fintiv Factors 2 and 4 Save Petitioner’s Request for Rehearing

December 17, 2021

Authored and Edited by Troy V Viger; Shannon M. Patrick; Amanda K. Murphy, Ph.D.

In SharkNinja Operating LLC v. iRobot Corp., No. IPR2021-00544, Paper 13 (PTAB Nov. 17, 2021), the PTAB granted the petitioner’s Request for Rehearing and Institution of Inter Partes Review (“IPR”).

The Board initially denied institution based on an analysis of the Fintiv factors.[1]  In its Request for Rehearing, the petitioner argued that the Board abused its discretion in denying institution.  The petitioner’s arguments centered on two of the four Fintiv factors: factor 2 (“proximity of the court’s trial date to the Board’s projected statutory deadline for a final written decision”) and factor 4 (“overlap between issues raised in the petition and in the parallel proceeding”).

In its initial Decision Denying Institution, the Board determined that Fintiv factor 2 weighed “in favor of exercising our discretion to deny institution” based on a parallel U.S. International Trade Commission investigation.  SharkNinja, IPR2021-00544, Paper 13.  In its Request for Rehearing, the petitioner argued that the Board mistakenly treated the ITC’s initial determination date as the final determination date and, consequentially, overlooked the target date for final determination.  Agreeing with the petitioner, the Board found that Fintiv factor 2 was neutral because of the close proximity between the ITC’s target date and the expected final written decision.

 In its initial Decision Denying Institution, the Board determined that Fintiv factor 4 weighed “marginally in favor of not exercising discretion to deny institution.”  SharkNinja, IPR2021-00544, Paper 13.  In its Request for Rehearing, the petitioner agreed to a broad stipulation of IPR estoppel.  As a result, the PTAB found that Fintiv factor 4 “weigh[ed] strongly in favor of not exercising [its] discretion to deny institution,” since the petitioner’s stipulation removed the concern of duplicative efforts between the three proceedings. Id. at 12.  The Board further noted that the stipulation promoted efficiency and would avoid conflicting decisions.

Concluding that the change in the Fintiv factor analysis justified rehearing and reconsideration of its previous decision, the Board considered the merits of the petition.  Ultimately, the Board determined that the petitioner showed a reasonable likelihood of establishing claim 1 of the challenged patent was obvious in light of the prior art and granted institution.


[1] Apple Inc. v. Fintiv, Inc., IPR2020-00019, Paper 11 (Mar. 20, 2020) (precedential) (“Fintiv”).

Tags

Patent Trial and Appeal Board (PTAB)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

Consumer Goods and Services

Consumer Products

Related Offices

Atlanta, GA

London

Contacts

Shannon M. Patrick
Associate
Atlanta, GA
+1 404 653 6558
Email
Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2814
Email

Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP